Your browser doesn't support javascript.
loading
A 10-step framework for use of read-across (RAX) in next generation risk assessment (NGRA) for cosmetics safety assessment.
Alexander-White, Camilla; Bury, Dagmar; Cronin, Mark; Dent, Matthew; Hack, Eric; Hewitt, Nicola J; Kenna, Gerry; Naciff, Jorge; Ouedraogo, Gladys; Schepky, Andreas; Mahony, Catherine; Europe, Cosmetics.
Afiliação
  • Alexander-White C; MKTox & Co Ltd, 36 Fairford Crescent, Downhead Park, Milton Keynes, Buckinghamshire, MK15 9AQ, UK. Electronic address: ckaw@mktoxconsult.com.
  • Bury D; L'Oreal Research & Innovation, 9 Rue Pierre Dreyfus, 92110, Clichy, France.
  • Cronin M; School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool L3 AF, UK.
  • Dent M; Unilever, Safety & Environmental Assurance Centre, Colworth House, Sharnbrook, Bedfordshire, MK44 1ET, UK.
  • Hack E; ScitoVation, Research Triangle Park, Durham, NC, USA.
  • Hewitt NJ; Cosmetics Europe, 40 Avenue Hermann-Debroux, 1160, Brussels, Belgium.
  • Kenna G; Cosmetics Europe, 40 Avenue Hermann-Debroux, 1160, Brussels, Belgium.
  • Naciff J; The Procter & Gamble Company, Cincinnati, OH, 45040, USA.
  • Ouedraogo G; L'Oreal Research & Innovation, 1 Avenue Eugène Schueller, Aulnay sous bois, France.
  • Schepky A; Beiersdorf, Unnastrasse 48, 20253, Hamburg, Germany.
  • Mahony C; Procter & Gamble Technical Centres Ltd, Reading, RG2 0RX, UK. Electronic address: mahony.c@pg.com.
  • Europe C; Cosmetics Europe, 40 Avenue Hermann-Debroux, 1160, Brussels, Belgium. Electronic address: cosmeticseurope@cosmeticseurope.eu.
Regul Toxicol Pharmacol ; 129: 105094, 2022 Mar.
Article em En | MEDLINE | ID: mdl-34990780
ABSTRACT
This paper presents a 10-step read-across (RAX) framework for use in cases where a threshold of toxicological concern (TTC) approach to cosmetics safety assessment is not possible. RAX builds on established approaches that have existed for more than two decades using chemical properties and in silico toxicology predictions, by further substantiating hypotheses on toxicological similarity of substances, and integrating new approach methodologies (NAM) in the biological and kinetic domains. NAM include new types of data on biological observations from, for example, in vitro assays, toxicogenomics, metabolomics, receptor binding screens and uses physiologically-based kinetic (PBK) modelling to inform about systemic exposure. NAM data can help to substantiate a mode/mechanism of action (MoA), and if similar chemicals can be shown to work by a similar MoA, a next generation risk assessment (NGRA) may be performed with acceptable confidence for a data-poor target substance with no or inadequate safety data, based on RAX approaches using data-rich analogue(s), and taking account of potency or kinetic/dynamic differences.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toxicologia / Cosméticos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Regul Toxicol Pharmacol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toxicologia / Cosméticos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Regul Toxicol Pharmacol Ano de publicação: 2022 Tipo de documento: Article